Bio-Thera Solutions (SHSE:688177) Total Equity: ¥224.1 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688177 Bio-Thera Solutions Ltd SHSE:688177
57 GF Score
Price ¥16.58
GF Value ¥33.46
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Bio-Thera Solutions Total Equity?

Bio-Thera Solutions SHSE:688177 -3.38% 57 Total Equity is ¥224.1 Mil as of Mar. 2026. GuruFocus rates SHSE:688177 with a GF Score™ of 57/100 and a GF Value™ of ¥33.46 (Possible Value Trap). The stock has 5 warning signs investors should review.

Bio-Thera Solutions's total equity for the quarter that ended in Mar. 2026 was ¥224.1 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Bio-Thera Solutions Total Equity Historical Data

* Premium members only.

The historical data trend for Bio-Thera Solutions's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Thera Solutions Total Equity Chart

Bio-Thera Solutions Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,087.51 1,607.26 1,212.72 708.09 376.03

Bio-Thera Solutions Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 614.73 583.12 484.17 376.03 224.12
SHSE:688177
57GF Score
Bio-Thera Solutions Ltd SHSE:688177
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio-Thera Solutions Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Bio-Thera Solutions's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=2287.322-1911.291
=376.0

Bio-Thera Solutions's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=2385.105-2160.982
=224.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ¥224.1 Mil mean?
Bio-Thera Solutions (SHSE:688177) has a Total Equity of ¥224.1 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Bio-Thera Solutions and its competitors.
Is Bio-Thera Solutions' Total Equity too high?
Bio-Thera Solutions' current Total Equity is ¥224.1 Mil. Overall, Bio-Thera Solutions has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bio-Thera Solutions' Total Equity compare to VRTX and REGN?
Bio-Thera Solutions' Total Equity of ¥224.1 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Bio-Thera Solutions and its competitors. Bio-Thera Solutions's current Total Equity is ¥224.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Thera Solutions stock overvalued right now?
Based on GuruFocus' analysis, Bio-Thera Solutions (SHSE:688177) is currently considered Possible Value Trap. The stock's GF Value™ is ¥33.46, compared to a current price of ¥16.58 — trading 50.4% below its estimated fair value. The current Total Equity is ¥224.1 Mil. Bio-Thera Solutions' overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Bio-Thera Solutions (SHSE:688177), the current Total Equity is ¥224.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bio-Thera Solutions (SHSE:688177) Overvalued in 2026?

Based on GuruFocus' analysis, Bio-Thera Solutions stock appears to be undervalued. The current stock price of ¥16.58 is trading 50.4% below its estimated GF Value™ of ¥33.46. GuruFocus considers Bio-Thera Solutions to be Possible Value Trap.

Key valuation signals for SHSE:688177:

  • Total Equity: ¥224.1 Mil
  • GF Value™: ¥33.46 vs. price of ¥16.58 (50.4% below fair value)
  • GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the SHSE:688177 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bio-Thera Solutions Business Description

Address 5th Floor, Building A6, 11 Kaiyuan Avenue, Guangzhou High-tech Industrial Development Zone, Science City, Guangdong Province, Guangzhou, CHN, 510530
Bio-Thera Solutions Ltd is engaged in research, development, and production of drugs and biosimilars. The company provides drug research and development; biotechnology consulting and communication services; services; medical research and experimental development; biological drug manufacturing; and pharmaceuticals retail.
57GF Score

Get the complete analysis for SHSE:688177

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥16.58
Price
¥33.46
GF Value